Duloxetine‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with neuropathic pain

Duloxetine‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with neuropathic pain

Key Clinical Message Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induces hyponatremia accompanied by uric acid reduction. We report a case of a patient with small‐cell lung cancer who developed SIADH with hypouricemia after duloxetine treatment and discuss the potential underlyi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical Case Reports 2024-11, Vol.12 (11), p.e9526-n/a
Hauptverfasser: Takahashi, Nobuyuki, Mori, Yukiko, Momo, Kenji, Murakami, Hidetomo, Tanaka, Hironori
Format: Artikel
Sprache:eng
Schlagworte:
Amino acids
Cancer patients
Care and treatment
Case Report
Development and progression
Drug dosages
duloxetine
General Medicine
Hyponatremia
Immunoglobulins
Lung cancer
Medical prognosis
neuropathic pain
Pain
Patients
Pharmacology and Pharmacy
Plasma
small‐cell lung cancer
Sodium
syndrome of inappropriate antidiuretic hormone secretion
Uric acid
Vasopressin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Key Clinical Message Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induces hyponatremia accompanied by uric acid reduction. We report a case of a patient with small‐cell lung cancer who developed SIADH with hypouricemia after duloxetine treatment and discuss the potential underlying mechanisms. SIADH and hypouricemia improved after duloxetine was switched to mirogabalin.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.9526